HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Still No Federal Agenda For Nanotech Safety Research; House Investigates

This article was originally published in The Rose Sheet

Executive Summary

Delays in the release of a fully articulated federal agenda for researching the environmental health and safety implications of nanotechnology were explored at a hearing held Oct. 31 by the House Science subcommittee on Research and Science Education

You may also be interested in...



Federal Plan For Nanotechnology Research Still Flawed, PEN Says

The federal government's newly released strategy for addressing priority research needs related to the environmental, health and safety implications of nanotechnology under its National Nanotechnology Initiative (NNI) still does not pass muster, according to the Project on Emerging Nanotechnologies (PEN)

Federal Plan For Nanotechnology Research Still Flawed, PEN Says

The federal government's newly released strategy for addressing priority research needs related to the environmental, health and safety implications of nanotechnology under its National Nanotechnology Initiative (NNI) still does not pass muster, according to the Project on Emerging Nanotechnologies (PEN)

EC Advises Against Studying Nano-Cosmetics In Humans Until Risks Are Known

Researchers should avoid clinical studies on nano-based cosmetics until more is known about their long-term effects, according to a Recommendation issued Feb. 7 by the European Commission (EC)

Related Content

UsernamePublicRestriction

Register

RS015074

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel